Literature DB >> 31428322

Antibiotic utilisation in adult and children patients in Kosovo hospitals.

Shaip Krasniqi1, Ann Versporten2, Arianit Jakupi3, Denis Raka4, Armond Daci4, Valon Krasniqi1, Zana Deva5, Albiona Rashiti5, Naime Brajshori6, Shefqet Hajdari6, Jetëmira Bytyqi6, Burim Neziri6, Herman Goossens2, Lul Raka5,6.   

Abstract

OBJECTIVES: There are no reliable data on antibiotic use in Kosovo hospitals. The aim of this survey was to monitor volumes and patterns of antibiotic use in hospitalised patients in order to identify targets for quality improvement.
METHODS: Data on antimicrobial use were collected from seven hospitals in Kosovo during 2013 using the standardised point prevalence survey (PPS) methodology as developed by the ESAC (European Surveillance of Antimicrobial Consumption) and ARPEC (Antibiotic Resistance and Prescribing in European Children). The survey included all inpatients receiving an antimicrobial agent on the day of the PPS.
RESULTS: Overall, 1667 patients were included in the study: adults 1345 (81%) and children 322 (19%). Of the hospital inpatients, 579/1345 (43%) adults and 188/322 (58%) children received at least one antibiotic during a hospital stay. The top three antibacterial subgroups (ATC level 3) were β-lactam antibiotics, cephalosporins and aminoglycosides. In all hospital centres, the most commonly prescribed antibiotic was ceftriaxone (39% for adult and 36% for children). Antibiotics were administered mainly parenterally in 74% of adults and 94% of children. Empirical prescribing was higher in adults 498/579 (86%) and children 181/188 (96%), compared with targeted treatment based on susceptibility testing-81 (14%) and 8 (4%), respectively.
CONCLUSIONS: Antibiotic use in Kosovo's hospitals is very high. Gathered data will be an important tool to identify targets for quality improvement and will support preparation of guidelines and protocols for the prudent use of antibiotics.

Entities:  

Keywords:  antibiotic use; point prevalence survey; surveillance

Year:  2017        PMID: 31428322      PMCID: PMC6684012          DOI: 10.1136/ejhpharm-2017-001363

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  29 in total

1.  Antibiotic use in developing countries.

Authors:  R E Istúriz; C Carbon
Journal:  Infect Control Hosp Epidemiol       Date:  2000-06       Impact factor: 3.254

Review 2.  Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-2004.

Authors:  Thomas A Parrino
Journal:  Pharmacotherapy       Date:  2005-02       Impact factor: 4.705

3.  Rebuilding a health care system: war, reconstruction and health care reforms in Kosovo.

Authors:  Dragudi Buwa; Hannu Vuori
Journal:  Eur J Public Health       Date:  2006-08-03       Impact factor: 3.367

4.  Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project.

Authors:  Michael A Borg; Peter Zarb; Matus Ferech; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2008-06-30       Impact factor: 5.790

5.  European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries.

Authors:  Brice Amadeo; Peter Zarb; Arno Muller; Nico Drapier; Vanessa Vankerckhoven; Anne-Marie Rogues; Peter Davey; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2010-08-16       Impact factor: 5.790

6.  A European study on the relationship between antimicrobial use and antimicrobial resistance.

Authors:  Stef L A M Bronzwaer; Otto Cars; Udo Buchholz; Sigvard Mölstad; Wim Goettsch; Irene K Veldhuijzen; Jacob L Kool; Marc J W Sprenger; John E Degener
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 7.  Clinical and economic burden of antimicrobial resistance.

Authors:  Lisa L Maragakis; Eli N Perencevich; Sara E Cosgrove
Journal:  Expert Rev Anti Infect Ther       Date:  2008-10       Impact factor: 5.091

Review 8.  Antibiotic consumption and link to resistance.

Authors:  H Goossens
Journal:  Clin Microbiol Infect       Date:  2009-04       Impact factor: 8.067

9.  Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics.

Authors:  Cheryl R Stein; David J Weber; Meera Kelley
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

10.  Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae.

Authors:  Chris A Van Beneden; Catherine Lexau; Wendy Baughman; Brenda Barnes; Nancy Bennett; P Maureen Cassidy; Margaret Pass; Lisa Gelling; Nancy L Barrett; Elizabeth R Zell; Cynthia G Whitney
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.